Skip to content
10-Q

Quarterly Report

Anthera Pharmaceuticals Inc

0001214659-17-006541

← back to feed
Filed
Nov 8, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Oct 31, 2017 13.85M sh
Operating Cash Flow Q3 2017 · Sep 30, 2017 −$30.64M
Operating Cash Flow Q3 2017 · Sep 30, 2016 −$36.69M
Cash And Equivalents Q3 2017 · Sep 30, 2017 $6.08M
Cash And Equivalents Q3 2017 · Dec 31, 2016 $20.84M
Cash And Equivalents Q3 2017 · Sep 30, 2016 $32.57M
Cash And Equivalents Q3 2017 · Dec 31, 2015 $46.95M
Stockholders Equity Q3 2017 · Sep 30, 2017 $343K
Stockholders Equity Q3 2017 · Dec 31, 2016 $12.47M
Current Liabilities Q3 2017 · Sep 30, 2017 $3.98M
Current Liabilities Q3 2017 · Dec 31, 2016 $10.62M
Total Liabilities Q3 2017 · Sep 30, 2017 $8.03M
Total Liabilities Q3 2017 · Dec 31, 2016 $10.62M
Current Assets Q3 2017 · Sep 30, 2017 $7.85M
Current Assets Q3 2017 · Dec 31, 2016 $22.71M
Total Assets Q3 2017 · Sep 30, 2017 $8.37M
Total Assets Q3 2017 · Dec 31, 2016 $23.47M
Sga Expense Q3 2017 · Sep 30, 2017 $1.81M
Sga Expense Q3 2017 · Sep 30, 2017 $6.34M
Sga Expense Q3 2017 · Sep 30, 2016 $2.5M
Sga Expense Q3 2017 · Sep 30, 2016 $7.32M
Rd Expense Q3 2017 · Sep 30, 2017 $6.1M
Rd Expense Q3 2017 · Sep 30, 2017 $20.94M
Rd Expense Q3 2017 · Sep 30, 2016 $14.1M
Rd Expense Q3 2017 · Sep 30, 2016 $35.69M
Net Income Q3 2017 · Sep 30, 2017 −$6.31M
Net Income Q3 2017 · Sep 30, 2017 −$17.2M
Net Income Q3 2017 · Sep 30, 2016 −$16.48M
Net Income Q3 2017 · Sep 30, 2016 −$42.54M
Operating Income Q3 2017 · Sep 30, 2017 −$7.91M
Operating Income Q3 2017 · Sep 30, 2017 −$27.18M
Operating Income Q3 2017 · Sep 30, 2016 −$16.6M
Operating Income Q3 2017 · Sep 30, 2016 −$42.6M
Capex Q3 2017 · Sep 30, 2016 $952K
Revenue Q3 2017 · Sep 30, 2016 $145K